Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson’s disease: a randomized phase 2 trial

医学 便秘 微生物群 粪便细菌疗法 随机对照试验 粪便 临床试验 内科学 胃肠病学 不利影响 移植 肠道菌群 功能性便秘 疾病 胃肠道 肠道微生物群 炎症性肠病 肠道通透性 疾病严重程度 发病机制 治疗效果 失调 临床研究阶段 生物信息学 免疫学 评定量表
作者
Rui Zhang,Renyi Feng,Jiuqi Wang,Yongkang Chen,Han Liu,Qingyong Zhu,Haiyan Tian,Chi Qin,Junfang Teng,Beisha Tang,Min Wu,Jinsheng Zeng,Erxi Wu,Xuebing Ding,Xuejing Wang
出处
期刊:Signal Transduction and Targeted Therapy [Springer Nature]
卷期号:11 (1) 被引量:19
标识
DOI:10.1038/s41392-026-02604-9
摘要

The gut-brain axis is increasingly recognized as a critical contributor to Parkinson's disease (PD) pathogenesis, yet the therapeutic impact of microbiota modulation remains unclear due to lack of clinical trials in drug-naïve patients. We conducted a randomized, double-blind, placebo-controlled phase 2 trial to evaluate the safety, tolerability, and efficacy of repeated donor fecal microbiota transplantation (dFMT) in de novo PD. FMT was administered for seven days (200 mL on days 1-3; 50 mL on days 4-7) per 4-week cycle. Seventy-two patients were randomized 1:1 to receive dFMT or autologous FMT (aFMT), and 66 completed the trial. At 35 weeks, the dFMT group showed significant improvement in motor symptoms (mean change in Unified Parkinson's Disease Rating Scale [UPDRS] III: -3.8 vs. +0.1; p = 0.0001) and a substantially greater reduction in constipation severity (dFMT vs. aFMT: -6.5 vs. -0.7; p < 0.0001), accompanied by improved quality-of-life scores. Microbiome profiling revealed greater similarity to donor composition and a marked reduction in Escherichia-Shigella, correlating with decreased colonic α-synuclein aggregation (r = 0.3775, p = 0.0277), supporting a gut-brain mechanistic link. Biochemical analyses showed elevated fecal dopamine and 3,4-dihydroxyphenylacetic acid levels, while histological assessments demonstrated strengthened epithelial barrier integrity with increased E-cadherin expression. All adverse events were mild and self-limited; no serious treatment-related events were observed. These findings demonstrate that repeated dFMT is safe, well tolerated, and yields clinically meaningful motor and gastrointestinal improvements in drug-naïve PD, providing integrated mechanistic and clinical evidence that microbiota-targeted modulation represents a promising nonpharmacologic therapeutic strategy for neurodegenerative disease. Trial registration: Chinese Clinical Trial Registry, ChiCTR2200064151.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
hwd完成签到,获得积分10
刚刚
凶狠的翅膀完成签到,获得积分10
刚刚
李爱国的应助被风中的宛白采纳,获得10
1秒前
清爽文博发布了新的文献求助10
1秒前
傲娇的半雪完成签到,获得积分10
1秒前
CipherSage的应助被lyl采纳,获得10
2秒前
fyy完成签到 ,获得积分10
2秒前
充电宝的应助被冰棍采纳,获得10
2秒前
molihuakai的应助被利物鸟贝拉采纳,获得10
3秒前
兖州牧完成签到 ,获得积分10
3秒前
崔小熊完成签到,获得积分10
3秒前
4秒前
4秒前
insist发布了新的文献求助10
4秒前
cc2004bj发布了新的文献求助10
4秒前
百里幻竹发布了新的文献求助10
5秒前
5秒前
星辰大海的应助被Wang采纳,获得10
5秒前
WINT发布了新的文献求助10
5秒前
飘逸的星星完成签到,获得积分10
6秒前
6秒前
yan完成签到,获得积分10
6秒前
Maestro_S的应助被achilles采纳,获得10
6秒前
7秒前
lay发布了新的文献求助10
7秒前
卓卓卓发布了新的文献求助10
7秒前
7秒前
无辜雨琴完成签到,获得积分10
7秒前
8秒前
Suifqh发布了新的文献求助10
8秒前
AZE完成签到,获得积分10
9秒前
Ding完成签到,获得积分10
9秒前
李少奇完成签到,获得积分10
9秒前
华仔的应助被小艾同学采纳,获得10
10秒前
10秒前
在水一方的应助被一地狗粮采纳,获得10
10秒前
江夏清完成签到,获得积分10
11秒前
低级研究生完成签到 ,获得积分10
11秒前
小蘑菇的应助被hhh采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181460
求助须知:如何正确求助?哪些是违规求助? 9571362
关于积分的说明 21817839
捐赠科研通 7777938
什么是DOI,文献DOI怎么找? 3433494
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479550